drugset / Trial / NCT00317512
Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization
RandomizedFactorialTriple-blindTreatment
Summary
The purpose of this study is to assess the safety and feasibility of a novel oxygen carrying solution, HBOC-201, in the setting of PCI for Acute Coronary Syndromes from randomization til hospital discharge.
Timeline
- Start
- 2003-12
- Primary completion
- 2005-04
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HBOC-201 | Protein / enzyme biologic | 15 g | Intravenous |
| Subject | HBOC-201 | Protein / enzyme biologic | 30 g | Intravenous |
| Comparator | hydroxyethyl starch | Other / unclassified | — | — |